This inventor holds 8 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Ideaya Biosciences, Inc., Glaxosmithkline Intellectual Property (No.4) Limited. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: Hilary Plake Beck: Innovator in Pharmaceutical Compounds
Introduction
Hilary Plake Beck is a notable inventor based in South San Francisco, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of 8 patents to his name, Beck's work is recognized for its potential impact on medical treatments.
Latest Patents
Among his latest patents, Beck has developed AhR modulators. These compounds, compositions, and methods are designed for the treatment of diseases modulated, at least in part, by AhR. The compounds are represented by specific formulae, with detailed meanings provided in the specification. Additionally, he has worked on dihydrothieno[3,2-b]pyridine compounds, which have utility in treating diseases, either alone or in combination with other agents.
Career Highlights
Beck is currently associated with Ideaya Biosciences, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing medical science through the development of novel compounds.
Collaborations
Throughout his career, Beck has collaborated with talented individuals such as Marcos Gonzalez-Lopez and James Clifford Sutton, Jr. These partnerships have contributed to the success of his projects and the advancement of their shared goals in the field of pharmaceuticals.
Conclusion
Hilary Plake Beck stands out as an influential inventor in the pharmaceutical industry, with a focus on developing innovative compounds for disease treatment. His contributions are paving the way for future advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile